Health in Sao Tome and Principe 1,223 indicators covering health for Sao Tome and Principe. IndicatorLatest Year10-yr change Rank Malaria cases reported 7,087 2024 up 304.0% 61st Mean systolic blood pressure 132.1 2009 up 0.8% 16th Mean fasting blood glucose (mmol/l) 5.4 2009 up 1.9% 71st HIV expenditure on prevention and treatment 0 constant 2019 US$ 2019 down 100.0% 101st Neonates protected at birth against neonatal tetanus (PAB) 99.0% 2022 unchanged 4th Number of new leprosy cases with G2D among children 0 2024 — 35th Percentage of people living with HIV who know their HIV status 97 2025 up 86.5% 6th Percentage of people living with HIV who know their status receiving 98 2025 unchanged 1st Most sold brand of cigarettes - price in PPP$ 2.81 2020 up 13.3% 151st Most sold brand of cigarettes - price in currency reported 30 2020 down 99.8% 98th Most sold brand of cigarettes - taxes as a % of price - total tax 0.3% 2020 up 36.0% 149th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.1% 2020 down 33.3% 77th Most sold brand of cigarettes - taxes as a % of price - import duties 0.1% 2020 down 28.6% 20th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 42nd Most sold brand of cigarettes - taxes as a % of price - value added 0.0% 2020 — 173rd Most sold brand of cigarettes - taxes as a % of price - specific 0.2% 2020 — 104th Most sold brand of cigarettes - price in US$ at official exchange 1.42 2020 up 34.0% 133rd Number of people who cannot afford a healthy diet 100,000 people 2024 unchanged 128th Number of one-year-olds who are not vaccinated against Streptococcus pneumoniae 875.14 one-year-olds 2023 up 379.2% 123rd Number of non-autochthonous leprosy cases 0 2024 — 47th Proportion of births delivered in a health facility (Facility births) 95.4% 2019 up 21.1% 72nd HPV immunization coverage estimates among primary target cohort (9-14) 97.0% 2025 — 5th Population with basic handwashing facilities at home 43.1% 2024 down 9.7% 62nd Tuberculosis - new and relapse cases 136 2011 up 40.2% 161st Diarrhea treatment 41.6% 2019 down 15.1% 49th Pregnant women receiving prenatal care 98.1% 2019 up 0.2% 20th New cases: pulmonary smear-negative 34 2012 down 8.1% 157th The number of people with susceptibility test result for rifampicin 0 2021 — 146th Total number of notified TB cases 158 2014 up 3.3% 159th New cases: pulmonary smear unknown/not done 3 2012 down 70.0% 98th Smear-positive tuberculosis treatment-success rate 72.0% 2011 up 14.3% 134th The number of people with susceptibility test result for rifampicin 0 2021 — 142nd Share of one-year-olds vaccinated against rotavirus 87.0% 2024 up 262.5% 38th Number of suspected malaria cases 240,774 2024 up 185.5% 66th Number of malaria positive cases by microscopy 7,118 2024 up 4,984.3% 53rd Number of presumed malaria cases 0 2024 — 40th Number of indigenous malaria cases 7,087 2024 up 244.7% 61st Number of confirmed malaria cases 7,118 2024 up 245.9% 62nd Total number of malaria cases 7,118 2024 up 245.9% 62nd Number of malaria suspects examined by microscopy 240,774 2024 up 1,916.4% 47th Retreatment cases: treatment after default 3 2012 — 118th Retreatment cases: treatment after failure 8 2012 up 166.7% 94th Yellow fever vaccine (YFV) immunization coverage among 1-year olds 91.0% 2013 up 167.6% 4th Number of indigenous P. falciparum malaria cases 7,087 2024 up 244.9% 52nd Retreatment cases: other 1 2012 — 115th Percentage of people living with HIV receiving treatment who have 78 2025 up 1.3% 83rd Expected funding for tuberculosis versus required budget 97,728 constant 2022 US$ 2025 up 83.5% 89th Antenatal care attendees who were positive for syphilis (%), reported 0.4% 2018 down 51.7% 61st Percentage of people living with HIV who have suppressed viral loads 76 2025 up 16.9% 38th Number of malaria positive cases by rapid diagnostic test 90 2023 down 95.3% 76th Number of reported deaths from cholera 4 2008 — 29th Average of 13 International Health Regulations core capacity scores 15.91 2017 down 33.7% 145th Number of malaria suspects examined by rapid diagnostic test 226,022 2023 up 212.2% 50th Domestic Expenditure on Malaria 3.71 million 2024 up 6,053.6% 25th Exclusive breastfeeding 63.1% 2019 up 25.4% 11th Laboratories providing tuberculosis diagnostic services using culture 0 2014 — 141st Laboratories providing tuberculosis diagnostic services using sputum 4.3 2014 up 514.3% 8th Vitamin A Supplementation, Semester 2 Coverage 38 2023 down 32.1% 46th Vitamin A Supplementation, Semester 1 Coverage 35 2023 down 40.7% 43rd تغطية بجرعتين من فيتامين أ 35 2023 down 37.5% 41st ← Previous Page 19 of 21 Next →